RESUMO
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are autoimmune mediated diseases triggered by group A streptococcal (GAS) infections. Molecular mimicry between GAS M-proteins and host tissue proteins has been proposed as the mechanism that initiates autoreactive immune responses in ARF/RHD. However, the individual role of antibodies and T-cells specific for GAS M-proteins in the pathogenesis of autoimmune carditis remains under-explored. The current study investigated the role of antibodies and T-cells in the development of carditis in the Lewis rat autoimmune valvultis (RAV) model by transferring serum and/or splenic T-cells from rats previously injected with GAS recombinant M5 protein. Here we report that serum antibodies alone and serum plus in vitro expanded rM5-specific T-cells from hyperimmune rats were capable of transferring carditis to naïve syngeneic animals. Moreover, the rats that received combined serum and T-cells developed more severe carditis. Recipient rats developed mitral valvulitis and myocarditis and showed prolongation of P-R intervals in electrocardiography. GAS M5 protein-specific IgG reactivity and T-cell recall response were also demonstrated in recipient rats indicating long-term persistence of antibodies and T-cells following transfer. The results suggest that both anti-GAS M5 antibodies and T-cells have differential propensity to induce autoimmune mediated carditis in syngeneic rats following transfer. The results highlight that antibodies and effector T-cells generated by GAS M protein injection can also independently home into cardiac tissue to cross-react with tissue proteins causing autoimmune mediated immunopathology.
Assuntos
Antígenos de Bactérias/toxicidade , Doenças Autoimunes , Proteínas da Membrana Bacteriana Externa/toxicidade , Proteínas de Transporte/toxicidade , Doenças das Valvas Cardíacas , Cardiopatia Reumática , Streptococcus pyogenes , Linfócitos T , Animais , Antígenos de Bactérias/imunologia , Doenças Autoimunes/induzido quimicamente , Doenças Autoimunes/imunologia , Doenças Autoimunes/patologia , Proteínas da Membrana Bacteriana Externa/imunologia , Proteínas de Transporte/imunologia , Feminino , Doenças das Valvas Cardíacas/induzido quimicamente , Doenças das Valvas Cardíacas/imunologia , Doenças das Valvas Cardíacas/patologia , Ratos , Ratos Endogâmicos Lew , Cardiopatia Reumática/induzido quimicamente , Cardiopatia Reumática/imunologia , Cardiopatia Reumática/patologia , Linfócitos T/imunologia , Linfócitos T/patologiaRESUMO
The eastern Russell's viper (Daboia siamensis) causes primarily hemotoxic envenomation. Applying shotgun proteomic approach, the present study unveiled the protein complexity and geographical variation of eastern D. siamensis venoms originated from Guangxi and Taiwan. The snake venoms from the two geographical locales shared comparable expression of major proteins notwithstanding variability in their toxin proteoforms. More than 90% of total venom proteins belong to the toxin families of Kunitz-type serine protease inhibitor, phospholipase A2, C-type lectin/lectin-like protein, serine protease and metalloproteinase. Daboia siamensis Monovalent Antivenom produced in Taiwan (DsMAV-Taiwan) was immunoreactive toward the Guangxi D. siamensis venom, and effectively neutralized the venom lethality at a potency of 1.41 mg venom per ml antivenom. This was corroborated by the antivenom effective neutralization against the venom procoagulant (ED = 0.044 ± 0.002 µl, 2.03 ± 0.12 mg/ml) and hemorrhagic (ED50 = 0.871 ± 0.159 µl, 7.85 ± 3.70 mg/ml) effects. The hetero-specific Chinese pit viper antivenoms i.e. Deinagkistrodon acutus Monovalent Antivenom and Gloydius brevicaudus Monovalent Antivenom showed negligible immunoreactivity and poor neutralization against the Guangxi D. siamensis venom. The findings suggest the need for improving treatment of D. siamensis envenomation in the region through the production and the use of appropriate antivenom.
Assuntos
Antivenenos/imunologia , Proteínas de Transporte , Daboia , Proteômica , Proteínas de Répteis , Venenos de Víboras , Animais , Proteínas de Transporte/antagonistas & inibidores , Proteínas de Transporte/imunologia , Proteínas de Transporte/toxicidade , China , Metaloproteases/imunologia , Camundongos , Camundongos Endogâmicos ICR , Fosfolipases A2/imunologia , Fosfolipases A2/toxicidade , Proteínas de Répteis/antagonistas & inibidores , Proteínas de Répteis/imunologia , Proteínas de Répteis/toxicidade , Serina Proteases/imunologia , Serina Proteases/toxicidade , Taiwan , Venenos de Víboras/antagonistas & inibidores , Venenos de Víboras/imunologia , Venenos de Víboras/toxicidadeRESUMO
Despite a huge number of studies, many aspects of the lipid transfer protein (LTP) syndrome, the most frequent primary food allergy in Mediterranean countries, remain unclear. Its peculiar geographical distribution, along with the extreme variability of its clinical expression, makes this type of food allergy something unique in the panorama of IgE-mediated food-induced allergic reactions. This review article tried to summarize the current knowledge about the most important aspects of LTP sensitization and allergy, along with the importance of positive and negative co-factors in the clinical expression of the syndrome as well as the issues regarding the cross-reactivity between LTPs present in botanically related and unrelated foods. Further, the possible absence of the protein from some plant foods is discussed.
Assuntos
Proteínas de Transporte , Hipersensibilidade Alimentar , Proteínas de Vegetais Comestíveis , Proteínas de Transporte/imunologia , Proteínas de Transporte/toxicidade , Reações Cruzadas , Hipersensibilidade Alimentar/epidemiologia , Hipersensibilidade Alimentar/imunologia , Hipersensibilidade Alimentar/patologia , Humanos , Imunoglobulina E/imunologia , Proteínas de Vegetais Comestíveis/imunologia , Proteínas de Vegetais Comestíveis/toxicidadeRESUMO
Toll-like receptors (TLRs) are innate immune receptors for sensing microbial molecules and damage-associated molecular patterns released from host cells. Double-stranded RNA and the synthetic analog polyinosinic:polycytidylic acid (poly(I:C)) bind and activate TLR3. This stimulation leads to recruitment of the adaptor molecule TRIF (Toll/IL-1 resistance (TIR) domain-containing adapter-inducing interferon ß) and activation of the transcription factors nuclear factor κB (NF-κB) and interferon regulatory factor 3 (IRF-3), classically inducing IFNß production. Here we report that, unlike non-metastatic intestinal epithelial cells (IECs), metastatic IECs express TLR3 and that TLR3 promotes invasiveness of these cells. In response to poly(I:C) addition, the metastatic IECs also induced the chemokine CXCL10 in a TLR3-, TRIF-, and IRF3-dependent manner but failed to produce IFNß. This was in contrast to healthy and non-metastatic IECs, which did not respond to poly(I:C) stimulation. Endolysosomal acidification and the endosomal transporter protein UNC93B1 was required for poly(I:C)-induced CXCL10 production. However, TLR3-induced CXCL10 was triggered by immobilized poly(I:C), was only modestly affected by inhibition of endocytosis, and could be blocked with an anti-TLR3 antibody, indicating that TLR3 can still signal from the cell surface of these cells. Furthermore, plasma membrane fractions from metastatic IECs contained both full-length and cleaved TLR3, demonstrating surface expression of both forms of TLR3. Our results imply that metastatic IECs express surface TLR3, allowing it to sense extracellular stimuli that trigger chemokine responses and promote invasiveness in these cells. We conclude that altered TLR3 expression and localization may have implications for cancer progression.
Assuntos
Quimiocina CXCL10/agonistas , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Neoplasias Intestinais/metabolismo , Proteínas de Neoplasias/agonistas , Receptor 3 Toll-Like/agonistas , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Proteínas de Transporte/toxicidade , Linhagem Celular , Linhagem Celular Tumoral , Quimiocina CXCL10/genética , Quimiocina CXCL10/metabolismo , Citocinas/agonistas , Citocinas/genética , Citocinas/metabolismo , Endocitose/efeitos dos fármacos , Humanos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/imunologia , Mucosa Intestinal/patologia , Neoplasias Intestinais/tratamento farmacológico , Neoplasias Intestinais/imunologia , Neoplasias Intestinais/patologia , Ligantes , Lipopolissacarídeos/toxicidade , Invasividade Neoplásica/imunologia , Invasividade Neoplásica/patologia , Invasividade Neoplásica/prevenção & controle , Proteínas de Neoplasias/antagonistas & inibidores , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Poli I-C , Polinucleotídeos/toxicidade , Regiões Promotoras Genéticas/efeitos dos fármacos , Transporte Proteico/efeitos dos fármacos , Proteólise/efeitos dos fármacos , Interferência de RNA , Receptor 3 Toll-Like/antagonistas & inibidores , Receptor 3 Toll-Like/genética , Receptor 3 Toll-Like/metabolismoRESUMO
Although adjuvants are a common component of many vaccines, there are few adjuvants licensed for use in humans due to concerns about their toxic effects. There is a need to develop new and safe adjuvants, because some existing vaccines have low immunogenicity among certain patient groups. In this study, SBP, a hepatitis B surface antigen binding protein that was discovered through screening a human liver cDNA expression library, was introduced into hepatitis B vaccine. A good laboratory practice, non-clinical safety evaluation was performed to identify the side effects of both SBP and SBP-adjuvanted hepatitis B vaccine. The results indicate that SBP could enhance the HBsAg-specific immune response, thus increasing the protection provided by the hepatitis B vaccine. The safety data obtained here warrant further investigation of SBP as a vaccine adjuvant.
Assuntos
Adjuvantes Imunológicos/administração & dosagem , Proteínas de Transporte/administração & dosagem , Antígenos de Superfície da Hepatite B/metabolismo , Vacinas contra Hepatite B/administração & dosagem , Adjuvantes Imunológicos/toxicidade , Animais , Proteínas de Transporte/imunologia , Proteínas de Transporte/toxicidade , Avaliação Pré-Clínica de Medicamentos , Feminino , Cobaias , Anticorpos Anti-Hepatite B/biossíntese , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B/imunologia , Vacinas contra Hepatite B/toxicidade , Humanos , Macaca fascicularis , Masculino , Camundongos , Camundongos Endogâmicos ICR , Ratos , Ratos Sprague-DawleyRESUMO
Size-dependent passive targeting based on the characteristics of tissues is a basic mechanism of drug delivery. While the nanometer-sized particles are efficiently captured by the liver and spleen, the micron-sized particles are most likely entrapped within the lung owing to its unique capillary structure and physiological features. To exploit this property in lung-targeting siRNA delivery, we designed and studied a multi-domain peptide named K-ß, which was able to form inter-molecular ß-sheet structures. Results showed that K-ß peptides and siRNAs formed stable complex particles of 60 nm when mixed together. A critical property of such particles was that, after being intravenously injected into mice, they further associated into loose and micron-sized aggregates, and thus effectively entrapped within the capillaries of the lung, leading to a passive accumulation and gene-silencing. The large size aggregates can dissociate or break down by the shear stress generated by blood flow, alleviating the pulmonary embolism. Besides the lung, siRNA enrichment and targeted gene silencing were also observed in the liver. This drug delivery strategy, together with the low toxicity, biodegradability, and programmability of peptide carriers, show great potentials in vivo applications.
Assuntos
Produtos Biológicos/farmacocinética , Proteínas de Transporte/química , Proteínas de Transporte/farmacocinética , Pulmão/metabolismo , RNA Interferente Pequeno/farmacocinética , Animais , Produtos Biológicos/toxicidade , Proteínas de Transporte/genética , Proteínas de Transporte/toxicidade , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Portadores de Fármacos , Humanos , Masculino , Camundongos Endogâmicos BALB C , Conformação Proteica , Conformação Proteica em Folha beta , Multimerização Proteica , RNA Interferente Pequeno/toxicidadeRESUMO
In this work, we analyzed the effects of coffee seed proteins, especially Cc-LTP1 on the larval development of Callosobruchus maculatus (F.) (Coleoptera: Bruchidae), a bruchid pest of beans and the most important insect pest of Vigna unguiculata (L.) Walp. Artificial seed assay, which incorporated the F/0-90 fraction from Coffea canephora seeds, resulted in the reduction of oviposition and caused an inhibition of C. maculatus larval development in a dose-dependent manner. The F/0-90 fraction used at a 4 % concentration resulted in the survival of no larvae. The purified Cc-LTP1, at a concentration of 0.5 %, also demonstrated effective inhibition of larval development, reducing both females oviposition and the weight and number of larvae. Cc-LTP1 was also able to inhibit the C. maculatus gut α-amylase activity, and immunolabeling by an anti-LTP serum was observed in the midgut tissues of the C. maculatus larvae. Cc-LTP1 has shown binding affinity towards microvillar cells, endoplasmic reticulum and mitochondria, as demonstrated by micrographic images taken by a transmission electron microscope. The results from this study indicate that Cc-LTP1 has insecticidal actions toward C. maculatus and exerts anti-nutritional effects with direct actions on intestinal tissues.
Assuntos
Proteínas de Transporte/toxicidade , Coffea/química , Besouros/efeitos dos fármacos , Larva/efeitos dos fármacos , Sementes/química , Animais , Besouros/crescimento & desenvolvimento , Feminino , Larva/crescimento & desenvolvimentoRESUMO
Streptococcal toxic shock syndrome (STSS) is associated with a high mortality rate. The M1 serotype of Streptococcus pyogenes is most frequently associated with STSS. Herein, we examined the role of Ras signaling in M1 protein-induced lung injury. Male C57BL/6 mice received the Ras inhibitor (farnesylthiosalicylic acid, FTS) prior to M1 protein challenge. Bronchoalveolar fluid and lung tissue were harvested for quantification of neutrophil recruitment, edema and CXC chemokine formation. Neutrophil expression of Mac-1 was quantified by use of flow cytometry. Quantitative RT-PCR was used to determine gene expression of CXC chemokines in alveolar macrophages. Administration of FTS reduced M1 protein-induced neutrophil recruitment, edema formation and tissue damage in the lung. M1 protein challenge increased Mac-1 expression on neutrophils and CXC chemokine levels in the lung. Inhibition of Ras activity decreased M1 protein-induced expression of Mac-1 on neutrophils and secretion of CXC chemokines in the lung. Moreover, FTS abolished M1 protein-provoked gene expression of CXC chemokines in alveolar macrophages. Ras inhibition decreased chemokine-mediated neutrophil migration in vitro. Taken together, our novel findings indicate that Ras signaling is a potent regulator of CXC chemokine formation and neutrophil infiltration in the lung. Thus, inhibition of Ras activity might be a useful way to antagonize streptococcal M1 protein-triggered acute lung injury.
Assuntos
Antígenos de Bactérias/toxicidade , Proteínas da Membrana Bacteriana Externa/toxicidade , Proteínas de Transporte/toxicidade , Quimiocinas CXC/imunologia , Lesão Pulmonar/induzido quimicamente , Macrófagos Alveolares/imunologia , Proteínas ras/metabolismo , Animais , Líquido da Lavagem Broncoalveolar/química , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Quimiocinas CXC/biossíntese , Ensaio de Imunoadsorção Enzimática , Farneseno Álcool/análogos & derivados , Farneseno Álcool/farmacologia , Citometria de Fluxo , Pulmão/efeitos dos fármacos , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/patologia , Lesão Pulmonar/imunologia , Lesão Pulmonar/metabolismo , Lesão Pulmonar/patologia , Macrófagos Alveolares/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Infiltração de Neutrófilos/efeitos dos fármacos , Infiltração de Neutrófilos/imunologia , Edema Pulmonar/induzido quimicamente , Edema Pulmonar/imunologia , Edema Pulmonar/metabolismo , Edema Pulmonar/patologia , Salicilatos/farmacologia , Transdução de Sinais/efeitos dos fármacos , Proteínas ras/antagonistas & inibidoresRESUMO
Recently, cell-penetrating peptides (CPPs) based vehicles have been developed for the delivery of different payloads in animals. Our studies have shown that nasal absorption of insulin and other therapeutic peptides and proteins can be improved significantly by co-administration of the CPP penetratin. Successful development of suitable CPP-based delivery systems, however, will depend not only on the efficiency of CPPs to transport therapeutic agents across the biological barriers of the nasal cavity, but also on the risk of adverse effects such as toxicity and undesired immunogenicity, especially in chronic therapy. In this study, we investigated the bioavailability (BA) of insulin and the adverse effects on the nasal mucosa in rats following a long-term dosing regimen of L-penetratin and the novel penetratin analogue "PenetraMax." Following nasal delivery, a significantly higher BA for insulin (almost 100% relative to subcutaneous (s.c.) injections) was observed for PenetraMax in comparison with the parent penetratin peptide after chronic administrations in rats. Importantly, there was negligible biomarker leakage in nasal lavage fluid and the integrity of the nasal epithelium remained unaffected when PenetraMax was used in long-term multiple administrations. In addition, no significant difference in the release of inflammatory and immunogenicity mediators in plasma was observed after nasal administration of PenetraMax with or without insulin solution. In conclusion, PenetraMax, a novel CPP candidate, can open a new avenue in clinical trials for noninvasive nasal insulin delivery.
Assuntos
Proteínas de Transporte/química , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Mucosa Nasal/efeitos dos fármacos , Administração Intranasal , Animais , Disponibilidade Biológica , Proteínas de Transporte/toxicidade , Peptídeos Penetradores de Células/química , Peptídeos Penetradores de Células/toxicidade , Portadores de Fármacos/química , Portadores de Fármacos/toxicidade , Sistemas de Liberação de Medicamentos , Hipoglicemiantes/farmacocinética , Hipoglicemiantes/toxicidade , Insulina/farmacocinética , Insulina/toxicidade , Masculino , Mucosa Nasal/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Testes de Toxicidade SubcrônicaRESUMO
PURPOSE OF REVIEW: Nonspecific lipid transfer protein (LTP) is the main cause of primary food allergy in adults living in the Mediterranean area. The way allergic patients get sensitized to this protein is all but established, and the clinical expression of sensitization is extremely variable, ranging from long-lasting symptomless sensitization to severe anaphylaxis. Such variability is seemingly due to the presence/absence of a number of cofactors. RECENT FINDINGS: The possibility that LTP sensitization occurs via the inhalation of LTP-containing pollen particles seems unlikely; in contrast, peach particles containing the protein seem able to sensitize both via the airways and the skin. Cosensitization to pollen allergens as well as to labile plant food allergens makes LTP allergy syndrome less severe. In some LTP sensitized subjects clinical food allergy occurs only in the presence of cofactors such as exercise, NSAIDs, or chronic urticaria. SUMMARY: Lipid transfer protein allergy syndrome shows some peculiarities that are unique in the primary food allergy panorama: geographical distribution, frequent asymptomatic sensitization, frequent need for cofactors, and reduced severity when pollen allergy is present. Future studies will have to address these points as the results may have favorable effects on other, more severe, types of food allergy.
Assuntos
Alérgenos/toxicidade , Anafilaxia , Antígenos de Plantas/toxicidade , Proteínas de Transporte/toxicidade , Proteínas de Plantas/toxicidade , Prunus/imunologia , Rinite Alérgica Sazonal , Adulto , Alérgenos/imunologia , Anafilaxia/epidemiologia , Anafilaxia/etiologia , Anafilaxia/imunologia , Antígenos de Plantas/imunologia , Proteínas de Transporte/imunologia , Hipersensibilidade Alimentar/epidemiologia , Hipersensibilidade Alimentar/etiologia , Hipersensibilidade Alimentar/imunologia , Humanos , Região do Mediterrâneo/epidemiologia , Proteínas de Plantas/imunologia , Rinite Alérgica Sazonal/complicações , Rinite Alérgica Sazonal/epidemiologia , Rinite Alérgica Sazonal/imunologiaRESUMO
Streptococcus pyogenes of the M1 serotype is frequently associated with severe streptococcal infections. M1 protein challenge can cause widespread microthrombosis, suggesting a role of platelets in streptococcal sepsis. Herein, we hypothesized that platelets may play a role in M1 protein-induced lung inflammation and injury. M1 protein was injected intravenously in C57Bl/6 mice. For platelet and neutrophil depletion, an anti-GP1bα antibody and an anti-Gr-1 antibody, respectively, were administered before M1 protein challenge. Bronchoalveolar fluid and lung tissue were harvested for analysis of neutrophil infiltration, edema, and macrophage inflammatory protein 2 (MIP-2) formation. Blood was collected for analysis of membrane-activated complex 1 (Mac-1) and CD40 ligand (CD40L) expression on neutrophils and platelets as well as soluble CD40L in plasma. M1 protein caused significant pulmonary damage characterized by neutrophil infiltration, increased formation of edema and MIP-2 in the lung, and enhanced Mac-1 expression on neutrophils. However, M1 protein challenge had no effect on platelet surface expression of CD40L or soluble CD40L levels in plasma. Interestingly, platelet depletion had no influence on M1 protein-induced neutrophil recruitment, MIP-2 production, and tissue damage in the lung or Mac-1 expression on neutrophils. Moreover, we observed that M1 protein could bind to neutrophils but not to platelets. On the other hand, neutrophil depletion abolished M1 protein-induced edema formation and tissue damage in the lung. Our data suggest that neutrophils but not platelets are involved in the pathophysiology of M1 protein-provoked pulmonary damage. Thus, neutrophils may constitute a key target in infections caused by S. pyogenes of the M1 serotype.
Assuntos
Antígenos de Bactérias/toxicidade , Proteínas da Membrana Bacteriana Externa/toxicidade , Plaquetas/fisiologia , Proteínas de Transporte/toxicidade , Lesão Pulmonar/sangue , Lesão Pulmonar/induzido quimicamente , Animais , Plaquetas/metabolismo , Ligante de CD40/metabolismo , Quimiocina CXCL2/metabolismo , Ensaio de Imunoadsorção Enzimática , Lesão Pulmonar/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Infiltração de Neutrófilos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Neutrófilos/metabolismo , Edema Pulmonar/metabolismoRESUMO
In this study, a standard strain of HSV-1 (strain SM(44)) was used to investigate the antiviral activity of the recombinant Cyanovirin-N (CV-N) against Herpes simplex virus type 1 (HSV-1) in vitro and in vivo. Cytopathic effect (CPE) and MTT assays were used to evaluate the effect of CV-N on HSV-1 in Vero cells. The number of copies of HSV-DNA was detected by real-time fluorescence quantitative PCR (FQ-PCR). The results showed that CV-N had a low cytotoxicity on Vero cells with a CC(50) of 359.03 ± 0.56 µg/mL, and that it could not directly inactivate HSV-1 infectivity. CV-N not only reduced the CPE of HSV-1 when added before or after viral infection, with a 50% inhibitory concentration (IC(50)) with 2.26 and 30.16 µg/mL respectively, but it also decreased the copies of HSV-1 DNA in infected host cells. The encephalitis model for HSV-1 infection was conducted in Kunming mice, and treated with three dosages of CV-N (0.5, 5 & 10 mg/kg) which was administered intraperitoneally at 2h, 3d, 5d, 7d post infection. The duration for the appearance of symptoms of encephalitis and the survival days were recorded and brain tissue samples were obtained for pathological examination (HE staining). Compared with the untreated control group, in the 5mg/kg CV-N and 10mg/kg CV-N treated groups, the mice suffered light symptoms and the number of survival days were more than 9 d and 14 d respectively. HE staining also showed that in 5mg/kg CV-N and 10mg/kg CV-N treated groups, the brain cells did not show visible changes, except for a slight inflammation. Our results demonstrated that CV-N has pronounced antiviral activity against HSV-1 both in vitro and in vivo, and it would be a promising new candidate for anti-HSV therapeutics.
Assuntos
Antivirais/farmacologia , Proteínas de Bactérias/farmacologia , Produtos Biológicos/farmacologia , Proteínas de Transporte/farmacologia , Herpesvirus Humano 1/efeitos dos fármacos , Animais , Antivirais/uso terapêutico , Antivirais/toxicidade , Proteínas de Bactérias/genética , Proteínas de Bactérias/uso terapêutico , Proteínas de Bactérias/toxicidade , Produtos Biológicos/genética , Produtos Biológicos/uso terapêutico , Produtos Biológicos/toxicidade , Proteínas de Transporte/genética , Proteínas de Transporte/uso terapêutico , Proteínas de Transporte/toxicidade , Sobrevivência Celular , Chlorocebus aethiops , Efeito Citopatogênico Viral , DNA Viral/análise , Modelos Animais de Doenças , Encefalite Viral/tratamento farmacológico , Feminino , Herpes Simples/tratamento farmacológico , Masculino , Camundongos , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacologia , Proteínas Recombinantes/uso terapêutico , Proteínas Recombinantes/toxicidade , Análise de Sobrevida , Sais de Tetrazólio/metabolismo , Tiazóis/metabolismo , Células VeroRESUMO
Cell-penetrating peptides (CPPs) are promising candidates for safe and efficient delivery vectors for a wide range of cargoes. However, any compound that is internalized into cells may affect the cell homeostasis. The plethora of possible biological responses makes large scale "omics" studies appealing approaches for hunting any unsuspected side-effects and evaluate the toxicity of drug candidates. Here we have compared the alterations in cytosolic metabolome of CHO cells caused by five representatives of the most common CPPs: transportan (TP), penetratin (pAntp), HIV Tat derived peptide (pTat), nonaarginine (R(9)) and model amphipathic peptide (MAP). Analysis was done by liquid chromatography-mass spectrometry techniques, principal component analysis and heatmap displays. Results showed that the intracellular metabolome was the most affected by TP followed by pTat and MAP. Only minor changes could be associated with pAntp or R(9) treatment. The cells could recover from a treatment with 5 microM TP, but no recovery was observed at higher concentration. Both metabolomic and control experiments showed that TP affected cellular redox potential, depleted energy and the pools of purines and pyrimidines. In conclusion, we have performed a metabolomic analysis comparing the safety of cell-penetrating peptides and demonstrate the toxicity of one of them.
Assuntos
Proteínas de Transporte/toxicidade , Permeabilidade da Membrana Celular , Portadores de Fármacos/toxicidade , Metabolômica , Peptídeos/toxicidade , Sequência de Aminoácidos , Animais , Células CHO , Proteínas de Transporte/química , Proteínas de Transporte/farmacologia , Cricetinae , Cricetulus , Portadores de Fármacos/química , Portadores de Fármacos/farmacologia , Glutationa/metabolismo , Dados de Sequência Molecular , Oxirredução , Peptídeos/química , Peptídeos/farmacologia , Permeabilidade/efeitos dos fármacosRESUMO
Repeated or continuous inflammation of the heart is one of the initiation factors for dilated cardiomyopathy (DCM). In previous studies, we established a DCM animal model by immunizing rats with cardiac C protein. In the present study, we analyze the role of matrix metalloproteinases (MMPs) in experimental autoimmune carditis (EAC) and subsequent DCM to elucidate the pathomechanisms of this disease. In this model, inflammation begins approximately 9 days after immunization. At that time, MMP activities were detected by in situ zymography. Real-time PCR analysis revealed continuous up-regulation of MMP-2 mRNA from 2 wk and thereafter. MMP-9 mRNA, however, had only a transient increase at 2 wk. Double staining with in situ zymography and cell markers demonstrated that gelatinase (MMP-2 and MMP-9)-expressing cells are infiltrating macrophages during the early stage and cardiomyocytes at later stages. Minocycline, which inhibits MMP-9 activities more strongly than MMP-2, significantly suppressed EAC, but an MMP-2-specific inhibitor, TISAM, did not affect the course of the disease. Furthermore, immunohistochemical examination revealed that minocycline treatment suppressed T cell and macrophage infiltration strongly, whereas TISAM did not. These findings indicate that MMP-9, but not MMP-2, is involved in the pathogenesis of the acute phase of EAC, and further suggest that MMP-9 inhibitors, minocycline and its derivatives, may be useful therapies for EAC and DCM.
Assuntos
Cardiomiopatia Dilatada/enzimologia , Proteínas de Transporte/toxicidade , Metaloproteinase 2 da Matriz , Metaloproteinase 9 da Matriz/fisiologia , Miocardite/enzimologia , Animais , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/enzimologia , Doenças Autoimunes/patologia , Cardiomiopatia Dilatada/tratamento farmacológico , Cardiomiopatia Dilatada/imunologia , Cardiomiopatia Dilatada/patologia , Progressão da Doença , Feminino , Mediadores da Inflamação/fisiologia , Masculino , Metaloproteinase 2 da Matriz/biossíntese , Metaloproteinase 2 da Matriz/fisiologia , Metaloproteinase 9 da Matriz/biossíntese , Inibidores de Metaloproteinases de Matriz , Miocardite/tratamento farmacológico , Miocardite/imunologia , Miocardite/patologia , Inibidores de Proteases/uso terapêutico , Ratos , Ratos Endogâmicos LewRESUMO
The cell penetrating peptide, penetratin (RQIKIWFQNRRMKWKK-NH2) showed potent antimicrobial activity (MIC: 0.5-4 microM) without any cytotoxicity against mammalian cells. This study investigated the effect of linking together two peptide chains of penetratin on antimicrobial and cytolytic activities and plausible mode of bactericidal action. Two-stranded penetratin was prepared by a simultaneous solid-phase synthesis of the two strands of a single lysine residue attached to the solid support. Two-stranded penetratin markedly increased cytolytic activity against human erythrocytes and NIH-3T3 mouse fibroblast cells without a significant effect on antimicrobial activity. This finding suggested that penetratin is active as a monomer to bacterial cells but as an oligomer to mammalian cells. Circular dichroism analysis revealed that the alpha-helical content of the membrane-bound penetratin was unaffected by two-stranded Lys-linkage. Penetratin had very weak ability in the depolarization of membrane potential of intact Staphylococcus aureus cells and the fluorescent dye leakage of calcein-entrapped negatively charged bacterial membrane-mimicking vesicles. In contrast, two-stranded penetratin significantly caused membrane depolarization and dye leakage. These results suggest that the two-stranded penetratin induces a significant change in its mode of bactericidal action from the intracellular-target mechanism to the membrane-targeting mechanism.
Assuntos
Antibacterianos/química , Peptídeos Catiônicos Antimicrobianos/química , Proteínas de Transporte/química , Proteínas de Transporte/farmacologia , Sequência de Aminoácidos , Animais , Antibacterianos/farmacologia , Antibacterianos/toxicidade , Peptídeos Catiônicos Antimicrobianos/farmacologia , Peptídeos Catiônicos Antimicrobianos/toxicidade , Proteínas de Transporte/toxicidade , Peptídeos Penetradores de Células , Células Cultivadas , Dicroísmo Circular , Citotoxinas/química , Citotoxinas/toxicidade , Eritrócitos/efeitos dos fármacos , Humanos , Lisina/química , Fluidez de Membrana/efeitos dos fármacos , Camundongos , Dados de Sequência Molecular , Células NIH 3T3RESUMO
Equine recurrent uveitis (ERU) is a wide spread disease of the eye, which is the main cause for blindness in horses worldwide. Meanwhile, ERU is also accepted as the only reliable spontaneous model for human autoimmune uveitis. We identified and characterized novel autoantigens by analyzing the autoantibody-binding pattern from ERU cases to the retinal proteome. Cellular retinaldehyde-binding protein (CRALBP) and malate dehydrogenase (MDH) were detected as novel ERU autoantigens by this approach. B- and T-cell autoreactivity was detected to both autoantigens in ERU cases. The evaluation of the pathological relevance of CRALBP and MDH brought surprising results. While CRALBP-induced uveitis with high incidence in rats and horses, MDH was only uveitogenic in Lewis rats, but not in the horse itself.
Assuntos
Doenças dos Cavalos/induzido quimicamente , Proteômica/métodos , Uveíte/veterinária , Animais , Autoantígenos/imunologia , Autoantígenos/toxicidade , Bordetella pertussis , Proteínas de Transporte/imunologia , Proteínas de Transporte/toxicidade , Doenças dos Cavalos/imunologia , Doenças dos Cavalos/metabolismo , Cavalos , Humanos , Malato Desidrogenase/imunologia , Malato Desidrogenase/toxicidade , Proteoma/imunologia , Ratos , Ratos Endogâmicos Lew , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/toxicidade , Recidiva , Retina/imunologia , Suínos , Linfócitos T/fisiologia , Uveíte/induzido quimicamente , Uveíte/imunologia , Uveíte/metabolismoRESUMO
Synphilin-1 was described as a protein interacting with alpha-synuclein and is commonly found in Lewy bodies, the pathological hallmark of Parkinson's disease (PD). Our group has previously described and characterized in vitro a mutation in the synphilin-1 gene (R621C) in PD patients. Providing the first characterization of synphilin-1 expression in an animal model, we here used adenoviral gene transfer to study the effects of wild-type (WT) and R621C synphilin-1 in dopaminergic neurons in mouse brain. As synphilin-1 is commonly used to trigger aggregation of alpha-synuclein in cell culture, we investigated not only non-transgenic C57Bl/6 mice but also A30P-alpha-synuclein transgenic animals. Both WT synphilin-1 and R621C synphilin-1 led to the formation of Thioflavine-S positive inclusions in C57Bl/6 mice and degeneration of dopaminergic neurons in the substantia nigra. R621C synphilin-1 induced more aggregate formation than WT synphilin-1 in A30P-alpha-synuclein transgenic mice, consistent with the role of the R621C mutation as a susceptibility factor for PD. Synphilin-1 expression may be used to improve current mouse models of PD, as it induced both the formation of aggregates and degeneration of dopaminergic neurons, two core characteristics of PD that have not been well reproduced with expression of alpha-synuclein.
Assuntos
Arginina/genética , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Proteínas de Transporte/toxicidade , Cisteína/genética , Mutação/genética , Degeneração Neural/induzido quimicamente , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Proteínas do Tecido Nervoso/toxicidade , Adenoviridae/fisiologia , Animais , Benzotiazóis , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/metabolismo , Expressão Gênica/efeitos dos fármacos , Vetores Genéticos/fisiologia , Proteínas de Fluorescência Verde/biossíntese , Proteínas de Fluorescência Verde/genética , Peptídeos e Proteínas de Sinalização Intracelular , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Substância Negra/efeitos dos fármacos , Substância Negra/metabolismo , Tiazóis/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismoRESUMO
This study simultaneously considered the phylogeny, fatty acid binding ability, and fungal toxicity of a large number of monocot nonspecific lipid transfer proteins (ns-LTP). Nine novel full-length wheat ns-LTP1 clones, all possessing coding sequences of 348 bp, isolated from abiotic- and biotic-stressed cDNA libraries from aerial tissues, exhibited highly conserved coding regions with 78 to 99 and 71 to 100% identity at the nucleotide and amino acid levels, respectively. Phylogenetic analyses revealed two major ns-LTP families in wheat. Eight wheat ns-LTP genes from different clades were cloned into the expression vector pPICZalpha and transformed into Pichia pastoris. Sodium dodecyl sulfate polyacrylamide gel electrophoresis, Western blotting, and in vitro lipid binding activity assay confirmed that the eight ns-LTP were all successfully expressed and capable of in vitro binding fatty acid molecules. A comparative in vitro study on the toxicity of eight wheat ns-LTP to mycelium growth or spore germination of eight wheat pathogens and three nonwheat pathogens revealed differential toxicities among different ns-LTP. Values indicating 50% inhibition of fungal growth or spore germination of three selected ns-LTP against six fungi ranged from 1 to 7 microM. In vitro lipid-binding activity of ns-LTP was not correlated with their antifungal activity. Using the fluorescent probe SYTOX Green as an indicator of fungal membrane integrity, the in vitro toxicity of wheat ns-LTP was associated with alteration in permeability of fungal membranes.
Assuntos
Antifúngicos/toxicidade , Proteínas de Transporte/metabolismo , Proteínas de Transporte/toxicidade , Proteínas de Plantas/metabolismo , Proteínas de Plantas/toxicidade , Triticum/metabolismo , Antifúngicos/metabolismo , Sítios de Ligação , Proteínas de Transporte/genética , Permeabilidade da Membrana Celular , Clonagem Molecular , Eletroforese em Gel de Poliacrilamida , Filogenia , Proteínas de Plantas/genéticaAssuntos
Proteínas de Transporte/toxicidade , Proteínas de Transporte/uso terapêutico , Proteínas de Choque Térmico HSP70/toxicidade , Proteínas de Choque Térmico HSP70/uso terapêutico , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Animais , Proteínas de Transporte/administração & dosagem , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Proteínas de Choque Térmico HSP70/administração & dosagem , Humanos , Camundongos , Transplante de Neoplasias , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/uso terapêutico , Proteínas Recombinantes/toxicidadeRESUMO
The use of CPPs (cell-penetrating peptides) as delivery vectors for bioactive molecules has been an emerging field since 1994 when the first CPP, penetratin, was discovered. Since then, several CPPs, including the widely used Tat (transactivator of transcription) peptide, have been developed and utilized to translocate a wide range of compounds across the plasma membrane of cells both in vivo and in vitro. Although the field has emerged as a possible future candidate for drug delivery, little attention has been given to the potential toxic side effects that these peptides might exhibit in cargo delivery. Also, no comprehensive study has been performed to evaluate the relative efficacy of single CPPs to convey different cargos. Therefore we selected three of the major CPPs, penetratin, Tat and transportan 10, and evaluated their ability to deliver commonly used cargos, including fluoresceinyl moiety, double-stranded DNA and proteins (i.e. avidin and streptavidin), and studied their effect on membrane integrity and cell viability. Our results demonstrate the unfeasibility to use the translocation efficacy of fluorescein moiety as a gauge for CPP efficiency, since the delivery properties are dependent on the cargo used. Furthermore, and no less importantly, the toxicity of CPPs depends heavily on peptide concentration, cargo molecule and coupling strategy.